This inventor holds 1 USPTO granted patent. Top assignees: Columbia University, Revolution Medicines, Inc., The University of North Carolina at Chapel Hill. Active years: 2026.
Company Filing History:
1 out of 2,551 
1 out of 40 
1 out of 1,325 
Years Active: 2026
Title: Urszula Wasko: Innovator in Cancer Treatment
Introduction
Urszula Wasko is a prominent inventor based in New York, NY (US), known for her significant contributions to cancer treatment research. She has developed innovative methods aimed at improving therapeutic outcomes for patients with pancreatic cancer. Her work focuses on overcoming resistance to pan-RAS inhibitors, which are critical in the treatment of this challenging disease.
Latest Patents
Urszula Wasko holds 1 patent titled "MYC amplification drives resistance to pan-RAS inhibitors in pancreatic cancer." This patent outlines methods of treating tumors by administering a combination of a RAS inhibitor and a TEAD inhibitor. The innovative approach aims to effectively treat tumors that are resistant to RAS inhibitor therapy, providing new hope for patients facing this aggressive form of cancer.
Career Highlights
Throughout her career, Urszula has made significant strides in cancer research. She has worked at esteemed institutions such as Columbia University and The University of North Carolina at Chapel Hill. Her research has been instrumental in advancing the understanding of tumor biology and developing targeted therapies.
Collaborations
Urszula has collaborated with notable professionals in her field, including Kenneth Paul Olive. These partnerships have enhanced her research efforts and contributed to the development of effective cancer treatment strategies.
Conclusion
Urszula Wasko's innovative work in cancer treatment exemplifies the impact of research and invention in the medical field. Her dedication to overcoming treatment resistance in pancreatic cancer is paving the way for improved patient outcomes.